We are live on ! Find out more
GDRX icon

GoodRx Holdings
GDRX

170 hedge funds and large institutions have $633M invested in GoodRx Holdings in 2024 Q4 according to their latest regulatory filings, with 53 funds opening new positions, 46 increasing their positions, 35 reducing their positions, and 47 closing their positions.

New
Increased
Maintained
Reduced
Closed

253% more call options, than puts

Call options by funds: $4.22M | Put options by funds: $1.2M

33% more funds holding in top 10

Funds holding in top 10: 3 → 4 (+1)

31% more repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 35

13% more first-time investments, than exits

New positions opened: 53 | Existing positions closed: 47

1% more funds holding

Funds holding: 168 → 170 (+2)

13.83% less ownership

Funds ownership: 144.32% → 130.49% (-14%)

36% less capital invested

Capital invested by funds: $988M → $633M (-$355M)

Holders
170
Holders Change
+2
Holders Change %
+1.19%
% of All Funds
2.24%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.05%
New
53
Increased
46
Reduced
35
Closed
47
Calls
$4.22M
Puts
$1.2M
Net Calls
+$3.02M
Net Calls Change
+$930K

Top Buyers

Rank Fund Capital Flow
1
ClearBridge Investments
ClearBridge Investments
New York
+$6.93M
2
LCM
Lakewood Capital Management
New York
+$6.41M
3
RCMNY
Rubric Capital Management (New York)
New York
+$6.18M
4
State Street
State Street
Massachusetts
+$4.51M
5
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$4.39M

Top Sellers

Rank Fund Capital Flow
1
T. Rowe Price Investment Management
T. Rowe Price Investment Management
Maryland
-$26.5M
2
SAM
Silvercrest Asset Management
New York
-$16.7M
3
American Century Companies
American Century Companies
Missouri
-$12.4M
4
Millennium Management
Millennium Management
New York
-$11.7M
5
WP
Woodline Partners
California
-$7.29M
Name Holding Trade Value Shares
Change 		Change in
Stake
Charles Schwab
26
Charles Schwab
California
$2.5M +$321K +58,465 +12%
Raymond James Financial
27
Raymond James Financial
Florida
$2.5M +$2.95M +537,530 New
GCP
28
GSA Capital Partners
United Kingdom
$2.08M +$1.55M +282,799 +171%
Northern Trust
29
Northern Trust
Illinois
$1.96M +$276K +50,256 +14%
Point72 Asset Management
30
Point72 Asset Management
Connecticut
$1.78M -$6.85M -1,245,687 -77%
ER
31
EVR Research
Virginia
$1.76M +$2.08M +378,663 New
Stifel Financial
32
Stifel Financial
Missouri
$1.66M -$81.4K -14,802 -4%
Morgan Stanley
33
Morgan Stanley
New York
$1.53M -$342K -62,182 -16%
Assenagon Asset Management
34
Assenagon Asset Management
Luxembourg
$1.5M -$341K -62,044 -16%
TAM
35
Tocqueville Asset Management
New York
$1.31M +$1.55M +281,700 New
T. Rowe Price Associates
36
T. Rowe Price Associates
Maryland
$1.19M +$311K +56,522 +28%
MCM
37
Moore Capital Management
New York
$1.11M +$1.31M +237,892 New
UBS Group
38
UBS Group
Switzerland
$1.09M +$738K +134,254 +135%
Allianz Asset Management
39
Allianz Asset Management
Germany
$1.07M -$207K -37,569 -14%
EGM
40
Engineers Gate Manager
New York
$1,000K +$708K +128,857 +150%
Bank of New York Mellon
41
Bank of New York Mellon
New York
$896K +$96.9K +17,633 +10%
Balyasny Asset Management
42
Balyasny Asset Management
Illinois
$870K +$1.03M +187,030 New
Barclays
43
Barclays
United Kingdom
$772K +$142K +25,815 +18%
Swiss National Bank
44
Swiss National Bank
Switzerland
$751K +$35.2K +6,400 +4%
JP Morgan Chase
45
JP Morgan Chase
New York
$748K +$751K +136,648 +562%
CMF
46
Counterpoint Mutual Funds
California
$727K +$860K +156,439 New
CSS
47
Cubist Systematic Strategies
Connecticut
$708K +$837K +152,312 New
UBS AM
48
UBS AM
Illinois
$697K +$340K +61,924 +70%
Bank of America
49
Bank of America
North Carolina
$696K -$1.48M -269,320 -64%
PGCM
50
Prescott Group Capital Management
Oklahoma
$626K +$220K +40,000 +42%
1
2
3 4 5

GDRX Hedge Fund Activity: Q4 2024 in Review

170 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in GoodRx Holdings (GDRX) for Q4 2024, worth a combined $633M — down 36% from $988M a quarter earlier.

Buyers outnumbered sellers: 53 funds opened new GDRX positions and 47 closed out — a net gain of 6 holders — while 46 added to existing stakes and 35 trimmed.

The largest buyer was ClearBridge Investments, opening a new position worth an estimated $6.93M. The largest seller was T. Rowe Price Investment Management, exiting entirely with an estimated $26.5M sold.

  • 170 institutional investors held GoodRx Holdings (GDRX) as of Q4 2024, up from 168 in Q3 2024.
  • Funds reported $633M of GoodRx Holdings stock for Q4 2024, down 36% quarter-over-quarter.
  • 53 funds opened new GoodRx Holdings positions in Q4 2024 and 47 closed out, a net change of +6 holders.
  • The largest GoodRx Holdings buyer in Q4 2024 was ClearBridge Investments, an estimated $6.93M added.
  • The largest GoodRx Holdings seller in Q4 2024 was T. Rowe Price Investment Management, an estimated $26.5M sold.

Based on aggregated 13F filings for Q4 2024.